INTUITIVE SURGICAL INC — Director's Dealing 2023

Apr 25, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2023-04-21

Reporting Person: DeSantis Robert (EVP & Chief Product Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-21	Common Stock	M	2184	$245.6	Acquired	11612	Direct
2023-04-21	Common Stock	S	2184	$297.9181	Disposed	9428	Direct
2023-04-21	Common Stock	M	1086	$242.3367	Acquired	10514	Direct
2023-04-21	Common Stock	S	1086	$297.9181	Disposed	9428	Direct
2023-04-21	Common Stock	M	273	$179.7	Acquired	9701	Direct
2023-04-21	Common Stock	S	273	$297.9988	Disposed	9428	Direct
2023-04-21	Common Stock	M	273	$177.9867	Acquired	9701	Direct
2023-04-21	Common Stock	S	273	$297.9988	Disposed	9428	Direct
2023-04-21	Common Stock	M	2444	$208.9	Acquired	11872	Direct
2023-04-21	Common Stock	S	2444	$297.9271	Disposed	9428	Direct
2023-04-21	Common Stock	S	1196	$297.9116	Disposed	8232	Direct
2023-04-21	Common Stock	S	1167	$297.8963	Disposed	7065	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-21	Non-Qualified Stock Option (right to buy)	$177.9867	M	273	Disposed	2030-02-28	Common Stock (273)	Direct
2023-04-21	Non-Qualified Stock Option (right to buy)	$179.7	M	273	Disposed	2030-05-11	Common Stock (273)	Direct
2023-04-21	Non-Qualified Stock Option (right to buy)	$208.9	M	2444	Disposed	2029-08-28	Common Stock (2444)	Direct
2023-04-21	Non-Qualified Stock Option (right to buy)	$242.3367	M	1086	Disposed	2030-08-28	Common Stock (1086)	Direct
2023-04-21	Non-Qualified Stock Option (right to buy)	$245.6	M	2184	Disposed	2031-02-26	Common Stock (2184)	Direct

Footnotes

F1: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.55 to $299.16 as follows: 656 shares sold at $296.55 to $297.55; 1.979 shares sold at $297.56 to $298.53; and 635 shares sold at $298.62 to $299.16. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.61 to $299.31 as follows: 116 shares sold at $296.61 to $297.00; 370 shares sold at $297.78 to $298.74; and 60 shares sold at $298.99 to $299.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.52 to $299.30 as follows: 612 shares sold at $296.52 to $297.52; 1.413 shares sold at $297.57 to $298.50; and 419 shares sold at $298.63 to $299.30. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.59 to $299.27 as follows: 271 shares sold at $296.59 to $297.41; 725 shares sold at $297.66 to $298.62; and 200 shares sold at $298.68 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.39 to $299.22 as follows: 216 shares sold at $296.39 to $297.12; 705 shares sold at $297.42 to $298.41; and 246 shares sold at $298.50 to $299.22. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F7: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.

F8: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.

F9: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.